(Q44177869)

English

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

phase III clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Cunningham

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

N C Tebbutt

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Norman

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

T Iveson

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

M Seymour

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

T Hickish

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

P Harper

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

N Maisey

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

K Mochlinski

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Y Prior

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

M Hill

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1568-1575

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

One-year survey of carcinoma of the oesophagus and stomach in Wales

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF273

21 January 2018

Identifiers

10.1093/ANNONC/MDF273

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44177869&oldid=2108301060"